======= PLAUR ======= == Gene Information == * **Official Symbol**: PLAUR * **Official Name**: plasminogen activator, urokinase receptor * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=5329|5329]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q03405|Q03405]] * **Interactions**: [[https://thebiogrid.org/search.php?search=PLAUR&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20PLAUR|Open PubMed]] * **OMIM**: [[https://omim.org/entry/173391|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes the receptor for urokinase plasminogen activator and, given its role in localizing and promoting plasmin formation, likely influences many normal and pathological processes related to cell-surface plasminogen activation and localized degradation of the extracellular matrix. It binds both the proprotein and mature forms of urokinase plasminogen activator and permits the activation of the receptor-bound pro-enzyme by plasmin. The protein lacks transmembrane or cytoplasmic domains and may be anchored to the plasma membrane by a glycosyl-phosphatidylinositol (GPI) moiety following cleavage of the nascent polypeptide near its carboxy-terminus. However, a soluble protein is also produced in some cell types. Alternative splicing results in multiple transcript variants encoding different isoforms. The proprotein experiences several post-translational cleavage reactions that have not yet been fully defined. [provided by RefSeq, Jul 2008]. * **UniProt Summary**: N/A |UPAR LY6| |urokinase plasminogen activator receptor activity| |urokinase plasminogen activator signaling pathway| |negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway| |invadopodium membrane| |regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway| |fibrinolysis| |positive regulation of release of cytochrome c from mitochondria| |positive regulation of epidermal growth factor receptor signaling pathway| |positive regulation of ERBB signaling pathway| |regulation of release of cytochrome c from mitochondria| |negative regulation of blood coagulation| |negative regulation of hemostasis| |negative regulation of coagulation| |positive regulation of DNA binding| |extrinsic component of membrane| |negative regulation of wound healing| |regulation of blood coagulation| |regulation of hemostasis| |negative regulation of cysteine-type endopeptidase activity involved in apoptotic process| |regulation of coagulation| |regulation of epidermal growth factor receptor signaling pathway| |negative regulation of response to wounding| |regulation of ERBB signaling pathway| |negative regulation of cysteine-type endopeptidase activity| |specific granule membrane| |negative regulation of intrinsic apoptotic signaling pathway| |anchored component of membrane| |positive regulation of mitochondrion organization| |regulation of DNA binding| |regulation of wound healing| |regulation of intrinsic apoptotic signaling pathway| |regulation of response to wounding| |positive regulation of apoptotic signaling pathway| |positive regulation of binding| |regulation of mitochondrion organization| |signaling receptor activity| |regulation of cysteine-type endopeptidase activity involved in apoptotic process| |negative regulation of apoptotic signaling pathway| |regulation of cysteine-type endopeptidase activity| |protein domain specific binding| |negative regulation of endopeptidase activity| |negative regulation of peptidase activity| |blood coagulation| |coagulation| |hemostasis| |endoplasmic reticulum lumen| |signaling receptor binding| |enzyme binding| |negative regulation of proteolysis| |negative regulation of response to external stimulus| |regulation of binding| |regulation of apoptotic signaling pathway| |focal adhesion| |regulation of endopeptidase activity| |regulation of peptidase activity| |negative regulation of hydrolase activity| |wound healing| |neutrophil degranulation| |neutrophil activation involved in immune response| |regulation of body fluid levels| |neutrophil mediated immunity| |neutrophil activation| |granulocyte activation| |negative regulation of intracellular signal transduction| |leukocyte degranulation| |myeloid leukocyte mediated immunity| |myeloid cell activation involved in immune response| |chemotaxis| |taxis| |response to wounding| |myeloid leukocyte activation| |cell surface| |positive regulation of organelle organization| |leukocyte activation involved in immune response| |cell activation involved in immune response| |positive regulation of apoptotic process| |positive regulation of programmed cell death| |positive regulation of cell death| |regulated exocytosis| |regulation of proteolysis| |leukocyte mediated immunity| |negative regulation of catalytic activity| |exocytosis| |negative regulation of apoptotic process| |negative regulation of programmed cell death| |leukocyte activation| |endoplasmic reticulum membrane| |negative regulation of cell death| |secretion by cell| |positive regulation of protein phosphorylation| |negative regulation of cellular protein metabolic process| |export from cell| |positive regulation of phosphorylation| |cell activation| |immune effector process| |regulation of response to external stimulus| |negative regulation of protein metabolic process| |secretion| |positive regulation of phosphate metabolic process| |positive regulation of phosphorus metabolic process| |negative regulation of molecular function| |negative regulation of multicellular organismal process| |positive regulation of cellular component organization| |positive regulation of protein modification process| |negative regulation of signal transduction| |regulation of hydrolase activity| |regulation of organelle organization| |locomotion| |negative regulation of cell communication| |negative regulation of signaling| |integral component of plasma membrane| |regulation of protein phosphorylation| |regulation of response to stress| |regulation of apoptotic process| |regulation of programmed cell death| |regulation of phosphorylation| |positive regulation of cellular protein metabolic process| |negative regulation of response to stimulus| |positive regulation of signal transduction| |regulation of cell death| |positive regulation of protein metabolic process| |positive regulation of molecular function| |regulation of phosphate metabolic process| |regulation of phosphorus metabolic process| |positive regulation of cell communication| |positive regulation of signaling| |regulation of intracellular signal transduction| |regulation of protein modification process| |immune response| |extracellular region| |vesicle-mediated transport| \\ === CRISPR Data === No hits were found. No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 3157 * **Expression level (log2 read counts)**: 3.96 {{:chemogenomics:nalm6 dist.png?nolink |}}